Table 2 Viral risk factors in the 30 patients with HCC
Serological and molecular features | n (%) |
|---|---|
HBsAg(+) | 19 (63.3) |
HBeAg(+) | 5 (16.6) |
anti-HBc(+) | 28 (92.5) |
anti-hepatitis B immunization | 3 (10.0) |
anti-HCV (+) | 14 (46.6) |
Co-infection HBsAg(+)/anti-HCV(+) | 8 (26.6) |
HBV DNA (+) | 14 (46.6) |
Genotype E | 14/14 (100.0) |